Recommendation
Kotak’s Buy Calls Recommendation - Sintex
Sintex
Price (Rs): 260
Target price (Rs): 310
Growth rebound and reasonable valuations.
Kotak expects robust 18% revenue growth (led by 40% growth in the monolithic segment) and 90 bps EBITDA margin expansion in FY2011E to drive a 21% EPS CAGR over FY2010E-FY2012E. The stock is trading at 9.2X FY2011E EPS. Outperformance in 4QFY10E versus KIE estimates - even [...]
Buy Calls - GSK Consumer
Investors seeking a defensive option for their portfolio can consider adding the GlaxoSmithkline Consumer Healthcare (GSK Consumer) stock. The current market price of Rs 1,496 discounts estimated 2011 earnings by about 18 times (Nestle and Dabur India trade at 24-26 times).
The company closed Calendar 2009 with sales growth of 25 per cent, managed almost evenly [...]
Dalal Street Choice Scrip Buy Calls - Biocon
Biocon
CMP: Rs. 262
Investment: 1 Year
Target: Rs. 343
With 30 million diabetic patients in India, Biocon is well-placed to deliver good growth ahead with its insulin portfolio. In diabetology the company is growing at a rapid rate of 40 per cent in the domestic segment. The company enjoys a market share of 12 per cent in the [...]
Buy Recommendation - Elgi Equipments
Revival in capex in the domestic market, manufacturing /trading presence in high potential developing markets such as China and Brazil and a strong cash position that allows scouting for acquisitions in new markets are factors that favour earnings growth for the company over the medium term.
At the current market price of Rs 80, Elgi’s stock [...]
Buy Recommendation - IndusInd Bank
One of the turnaround stories in the banking industry, IndusInd Bank continues to be a good investment opportunity for investors with a penchant for risk. The return on equity (ROE) of the bank is expected to be improved from 10 per cent in 2008-09 to 17.5 per cent this fiscal, helped by improved net interest [...]
Buy Recommendation - Piramal Healthcare
Investors with a long-term perspective can consider accumulating the stock of Piramal Healthcare, company with a strong presence in the domestic pharmaceutical market, established relationships with several global pharma majors, and its firming hold over the high-margin inhalation anesthetics space. Valuations too appear reasonable. At current market price of Rs 397, the stock discounts its [...]
Dalal Street Low Priced Scrip: Welspun India Ltd
Welspun India
CMP: Rs 77
Target: 20-25% Appreciation
Investment: 12-18 months
Welspun India (WIL) part of USD 3 billion Welspun group and among Asia’s largest terry towels manufacturers is one of the few companies consistently beating the street expectation since last few quarters. This commendable performance is on the backdrop of US reeling under the recession, which is company’s [...]
Protected: Buy Recommendation: Transformers & Rectifiers
There is no excerpt because this is a protected post.
Protected: Dalal Street Choice Scrip - CESC - 30% Gains in One Year
There is no excerpt because this is a protected post.
Protected: Dalal Street Low Priced Scrip - Himatsingka Seide
There is no excerpt because this is a protected post.
